Oxford Biomedica Solutions to Present Company Capabilities & Its Platform at Cell & Gene Meeting on the Mesa and European Society of Gene & Cell Therapy

2022-10-05
GlobeNewswire-Health Care
基因疗法细胞疗法
Oxford Biomedica Solutions to Present Company Capabilities & Its Platform at Cell & Gene Meeting on the Mesa and European Society of Gene & Cell Therapy
BEDFORD, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Oxford Biomedica Solutions LLC, an Oxford Biomedica company that offers an end-to-end, full solution platform approach to the development and production of Adeno-Associated Virus (AAV) vectors used in gene therapy, will be presenting a Company overview and providing updates on its industry leading capabilities at upcoming Industry conferences.
Cell & Gene Meeting on the Mesa
Presenter:
Tim Kelly, CEO, Oxford Biomedica Solutions Date:
Tuesday 11 Oct 2022 Time:
14:15 – 15:30 (PT); 17:15 – 18:30 (ET) Location:
Park Hyatt Aviara Resort, Carlsbad, CA Virtual attendance is available which includes a livestream of Oxford Biomedica Solutions’ presentation and the ability to view all conference sessions on-demand. Please visit https://meetingonthemesa.com for full information including registration.
The Oxford Biomedica Solutions platform has now demonstrated performance of 1E15 vg/L titer, greater than 90% fully intact vector, formulation stability at 2-8ºC, and consistency across hundreds of constructs and all serotypes tested. A sampling of the technical breadth and capability will be shared at the upcoming ESGCT conference.
Location: Edinburgh International Conference Center, Edinburgh, Scotland
Date: Wednesday 12 October 2022
1)Analytical characterization of empty, partial, and full AAV capsids. Poster # P265. 2)Achieving AAV vector productivity >1E15 vg/L and scaling suspension transfection to 2,000L through upstream process optimization. Poster # P257.
Date: Thursday 13 October 2022
3)Novel AAV drug product formulation achieving long-term liquid state stability (2-8°C) and high titer preparations (>E15vg/mL). Poster # P306. Contact:
www.oxbsolutions.com
T: +781.428.4536/ E: solutions.partnering@oxb.com
Oxford Biomedica Solutions offers a plug and play platform that is capable of achieving both high titer and high product quality vector for partners. The platform has already been proven with six INDs and CTAs. High titer, high product quality, proven expertise, and speed are the foundation of the platform. This unique platform and fully integrated end-to-end capabilities, from vector design and process development through to clinical trials, are now available to partners. For more information contact us at solutions.partnering@oxb.com.


更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。